Generics 139

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Lamivudine manufacturers

139 products found

Filters

lamivudine + zidovudine

Tablets, film coated 150 mg + 300 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP, Netherlands
Unavailable markets
Chile , Turkey , Vietnam , Panama , Mexico , Guatemala , Honduras , Nicaragua , El Salvador , Costa Rica , Belize , Haiti , Cuba , Dominican Republic , Jamaica , Bahamas , Barbados , Grenada , Antigua And/Or Barbuda , Dominica , Brazil , Colombia , Argentina
Registered in
Germany
Available for
Licensing with supply
Manufacturer #261
A pharmaceutical manufacturer based in the EU that has been selling its products in Europe for 20+ years. Main therapeutic areas include diabetes, CNL, dermatology, and oncology. Main dosage forms include solid and liquid oral, sterile dosage forms, and ointments. The company possesses 10+ manufacturing facilities that are cGMP-compliant.

Manufacturer usually replies in 6 days

lamivudine + abacavir

Tablets 300 mg + 600 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Manufacturer #15189
The company, which was founded in 1989, is involved in developing, manufacturing, and distributing a wide range of formulations for anti-infectives, cardiovascular, anti-diabetic, dermatological, and hormone treatment. The corporation has a global presence in 170 + countries, 60+ WHO-prequalified medications, and 3700+ product registrations.

Manufacturer usually replies in 9 days

lamivudine

Tablets, film coated 150 mg, 300 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Unavailable markets
Chile , Turkey , Vietnam , Panama , Mexico , Guatemala , Honduras , Nicaragua , El Salvador , Costa Rica , Belize , Haiti , Cuba , Dominican Republic , Jamaica , Bahamas , Barbados , Grenada , Antigua And/Or Barbuda , Dominica , Brazil , Colombia , Argentina
Available for
Licensing with supply
Manufacturer #261
A pharmaceutical manufacturer based in the EU that has been selling its products in Europe for 20+ years. Main therapeutic areas include diabetes, CNL, dermatology, and oncology. Main dosage forms include solid and liquid oral, sterile dosage forms, and ointments. The company possesses 10+ manufacturing facilities that are cGMP-compliant.

Manufacturer usually replies in 6 days

Want to see all 139 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Lamivudine Manufacturers

Lamivudine is an antiretroviral medication used to treat as well as prevent HIV/ AIDS. Manufacturers of lamivudine produce both standalone formulations of the drug as well as use it in combination with other antiretroviral class drugs, such as zidovudine and abacavir. Lamivudine suppliers market it in the form of 100mg, 150mg and 300mg tablets, 150mg/300mg lamivudine/ zidovudine tablets and 600mg/ 300mg abacavir/ lamivudine tablets. Following medical approval in 1995, the earliest manufacturer of lamivudine was GlaxoSmithKline. The medication has since become included in the WHO’s list of Essential Medicines that contains the most effective/ safest drugs recommended for a basic health system. What is more, other lamivudine manufacturers and suppliers, such as Apotex, Auro Pharma, Lupin, Zydus, and Cipla have joined the market with their formulations. Lamivudine suppliers and distributors market both generic and trade name formulations of the drug. Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified lamivudine manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform. A four-week treatment of lamivudine was found to be both safe and effective in suppressing HBV DNA in Chinese HBsAg carriers. The suppression was more than 90%, but it was reversible. Long-term lamivudine administration should be studied to see if HBV DNA can be suppressed for an extended period of time. If you have or have had liver problems, such as hepatitis B virus infection (HBV) or hepatitis C virus infection, you should not use lamivudine (HCV). If you have kidney issues. If you suffer from diabetes. 3 grammes of sucrose are contained in each 15-mL dose (150 mg) of lamivudine oral solution (common table sugar).

How does Lamivudine work?

Lamivudine (Epivir-HBV) is a medication used to treat hepatitis B. Lamivudine belongs to a class of drugs known as nucleoside reverse transcriptase inhibitors (NRTIs). It works by lowering the concentration of HIV and hepatitis B in the blood. Lamivudine must be converted intracellularly to its triphosphate form, which competes for inclusion into the growing viral DNA strand with cytosine triphosphate. This leads in chain termination and the termination of viral DNA replication.

The Cost of Lamivudine

An online search for the wholesale price for sale of Lamivudine for distributors will reveal a wide range of costs. It will vary from store to store depending on your visit and the country of the wholesale market. The prices of lamivudine medications depend on whether it is a generic or trade name formulation, on the concentration of the active ingredient in the formulation, other ingredients that are contained in the formulation as well as supplier and manufacturer pricing. For example, 60 (150mg) tablets of lamivudine cost approximately 200 EUR, whereas the equivalent amount of 150mg/ 300mg lamivudine/ zidovudine tablets can cost between 150 EUR to 300 EUR, and the 600mg/ 300mg abacavir/ lamivudine tablet cost falls into an approximate range of 100 EUR to 150 EUR.

Navigating our pharmaceutical marketplace

Being a global B2B pharmaceutical online marketplace, Pipelinepharma is structured to simplify pharmaceutical deals by providing you with an intuitive interface that is easy to engage with. The selection of Lamivudine distributors offerings can be narrowed down with the use of filters and easily weighed against one another according to medication prices and commercial terms. The advanced filters help you filter out the countries for these substance manufacturers and this substance Lamivudine suppliers that you are looking for. These also enable you to check the dossier status of this medicine and the GMP approvals of the different variants of Lamivudine. Also, each manufacturer or supplier product description contains essential information about this substance including clinical data, stability zones, countries where Lamivudine is already registered in. Manufacturers also have special, and delivery terms.

Establishing commercial ties

If you are a pharmaceutical licensing company or a distributor you can enter into deals or negotiations over these medicine offers with manufacturing companies after completing the free registration process and joining our online marketplace. This helps to ensure that you conclude the pharmaceutical product deal at a reasonable cost and achieve the best cost/benefit ratio for your company while bypassing lengthy sourcing, negotiation, and order process. Once you have finalized a deal, you can look forward to a long-lasting business relationship with the manufacturers Lamivudine suppliers. This way, the marketplace allows you as a distributor to skip the process of shortlisting product manufacturers every time you are looking for in-licensing or distribution deals.

Quality Assurance

To keep up to the quality standards other than Good Manufacturing Practice approvals that this medicine manufacturers list has, we qualify their companies before they are onboarded on the platform. This allows us to screen Lamivudine for the quality of the pharmaceutical products’ dossiers and protect against the risk of possible malpractices.

Interested in becoming a subscriber?

Please provide the following information to receive an offer tailored to your business needs

  1. Number of company users for the subscription
  2. The rough number of products you would like to source in the 12 months
  3. Target market(s) for commercialisation